Capital Impact Advisors LLC purchased a new stake in shares of Berkeley Lights, Inc. (NASDAQ:BLI – Get Rating) during the 3rd quarter, Holdings Channel reports. The fund purchased 21,805 shares of the company’s stock, valued at approximately $65,000.
Several other hedge funds have also added to or reduced their stakes in the company. Caxton Associates LP acquired a new position in Berkeley Lights during the 3rd quarter valued at about $53,000. Nierenberg Investment Management Company Inc. lifted its holdings in Berkeley Lights by 162.5% in the third quarter. Nierenberg Investment Management Company Inc. now owns 2,061,723 shares of the company’s stock valued at $5,897,000 after buying an additional 1,276,411 shares during the period. Lazard Asset Management LLC boosted its stake in Berkeley Lights by 3.9% in the third quarter. Lazard Asset Management LLC now owns 549,096 shares of the company’s stock valued at $1,570,000 after acquiring an additional 20,381 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in Berkeley Lights by 19.5% during the 3rd quarter. Russell Investments Group Ltd. now owns 72,074 shares of the company’s stock worth $205,000 after acquiring an additional 11,762 shares during the period. Finally, Virtu Financial LLC bought a new stake in shares of Berkeley Lights during the 3rd quarter valued at $37,000. Institutional investors own 68.43% of the company’s stock.
Berkeley Lights Stock Up 2.4 %
NASDAQ:BLI opened at $1.30 on Friday. The company has a quick ratio of 3.48, a current ratio of 3.89 and a debt-to-equity ratio of 0.10. Berkeley Lights, Inc. has a 12-month low of $1.20 and a 12-month high of $7.79. The stock’s fifty day simple moving average is $1.93 and its 200-day simple moving average is $2.53. The firm has a market capitalization of $93.82 million, a P/E ratio of -0.91 and a beta of 1.36.
Berkeley Lights Profile
Berkeley Lights, Inc, a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software.
- Get a free copy of the StockNews.com research report on Berkeley Lights (BLI)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Want to see what other hedge funds are holding BLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Berkeley Lights, Inc. (NASDAQ:BLI – Get Rating).
Receive News & Ratings for Berkeley Lights Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Berkeley Lights and related companies with MarketBeat.com's FREE daily email newsletter.